Jubilant Life Sciences Ltd – Strategy, SWOT and Corporate Finance Report

Jubilant Life Sciences Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Jubilant Life Sciences Ltd (Jubilant) is an integrated pharmaceutical and life sciences company that provides pharmaceuticals, life science ingredients and drug discovery solutions. The company’s product portfolio includes radiopharmaceuticals, allergy therapy products, active pharmaceutical ingredients (APIs), solid dosage formulations, life science chemicals, nutritional products, fine ingredients, advance intermediates and crop science ingredients. It also provides contract manufacturing of sterile injectables and drug discovery and development services. The company caters its products and services to customers across India, North America, Canada, Europe and China. It owns and operates cGMP compliant manufacturing facilities, and research and development centers in India, the US and Canada. Jubilant is headquartered in Noida, Uttar Pradesh, India.

Scope

Detailed information on Jubilant Life Sciences Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Jubilant Life Sciences Ltd in the form of a SWOT analysis

An in-depth view of the business model of Jubilant Life Sciences Ltd including a breakdown and examination of key business segments

News about Jubilant Life Sciences Ltd, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Jubilant Life Sciences Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Jubilant Life Sciences Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Jubilant Life Sciences Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Teva Pharmaceutical Industries Ltd

Tata Chemicals Ltd

Hetero Drugs Ltd

Dr. Reddy's Laboratories Ltd

Divi's Laboratories Ltd

BASF India Ltd

Atul Ltd

Aditya Birla Chemicals (India) Ltd

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Jubilant Life Sciences Ltd - Key Facts 6

Jubilant Life Sciences Ltd - Key Employees 7

Jubilant Life Sciences Ltd - Key Employee Biographies 8

Jubilant Life Sciences Ltd - Key Operational Employees 9

Jubilant Life Sciences Ltd - Major Products and Services 10

Jubilant Life Sciences Ltd - History 12

Jubilant Life Sciences Ltd - Company Statement 18

Jubilant Life Sciences Ltd - Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Section 2 Company Analysis 22

Company Overview 22

Jubilant Life Sciences Ltd - Business Description 23

Business Segment: Drug Discovery Solutions 23

Overview 23

Performance 23

Business Segment: Life Science Ingredients 23

Overview 23

Performance 23

Business Segment: Pharmaceuticals 23

Overview 23

Performance 23

Geographical Segment: Americas and Europe 24

Performance 24

Geographical Segment: China 24

Performance 24

Geographical Segment: India 24

Performance 24

Geographical Segment: Rest of the world 24

Performance 24

R&D Overview 24

Jubilant Life Sciences Ltd - Corporate Strategy 25

Jubilant Life Sciences Ltd - SWOT Analysis 26

SWOT Analysis - Overview 26

Jubilant Life Sciences Ltd - Strengths 26

Jubilant Life Sciences Ltd - Weaknesses 27

Jubilant Life Sciences Ltd - Opportunities 28

Jubilant Life Sciences Ltd - Threats 29

Jubilant Life Sciences Ltd - Key Competitors 30

Section 3 Company Financial Ratios 31

Financial Ratios - Capital Market Ratios 31

Financial Ratios - Annual Ratios 32

Performance Chart 35

Financial Performance 35

Financial Ratios - Interim Ratios 36

Financial Ratios - Ratio Charts 37

Section 4 Company’s Lifesciences Financial Deals and Alliances 38

Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 38

Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 39

Jubilant Life Sciences Ltd, Recent Deals Summary 40

Section 5 Company’s Recent Developments 41

Jul 27, 2018: Jubilant Life Sciences- Q1 FY 2019 Results Jubilant Reports Strong Performance in Q1’FY19 Revenue at Rs. 2,079 Crore, up 34% YoY 41

May 09, 2018: Jubilant Life Sciences Q4/ FY2018 Results- Jubilant Reports Strong Performance in Q4’FY18 Revenue at Rs. 2,252 crore, up 41% YOY; EBITDA at Rs. 481 crore, up 52% YOY PAT at Rs 155 crore 44

Mar 04, 2018: Jubilant Life Sciences: Commissioner of State Excise Cancelled License DS-1 License and Form-I License relating to the Distillery operations 48

Jan 17, 2018: Jubilant Reports Record Performance In Q3 FY2018; Highest Ever Revenues And Profits Revenue At Rs. 2,068 Crore, Up 42% YOY and Ebitda at Rs. 431 Crore, Up 28% YOY Pat At Rs. 213 Crore, Up 78% YOY With 49

Jan 17, 2018: Jubilant Life Sciences: Changes in the Board of Directors 53

Oct 28, 2017: Jubilant Life Sciences: Q2/H1 FY2018 Results 54

Aug 21, 2017: Jubilant Receives NDA Approval for Drax Exametazime 58

Jul 18, 2017: Jubilant Life Sciences: Q1 FY2018 Result 59

Jul 18, 2017: Jubilant Reports Q1 FY2018 Revenue of Rs. 1,596 Crore, UP 10% YOY Pharma Segment Records Highest Ever Sales Ebitda of Rs. 344 Crore and Margins of

21.6%; Pat of Rs. 147 Crore 61

Jun 01, 2017: Jubilant Life Sciences Provides Update on Gajraula Manufacturing Unit 63

Section 6 Appendix 64

Methodology 64

Ratio Definitions 64

About GlobalData 68

Contact Us 68

Disclaimer 68

List of Tables

List of Tables

Jubilant Life Sciences Ltd, Key Facts 6

Jubilant Life Sciences Ltd, Key Employees 7

Jubilant Life Sciences Ltd, Key Employee Biographies 8

Jubilant Life Sciences Ltd, Key Operational Employees 9

Jubilant Life Sciences Ltd, Major Products and Services 10

Jubilant Life Sciences Ltd, History 12

Jubilant Life Sciences Ltd, Other Locations 19

Jubilant Life Sciences Ltd, Subsidiaries 20

Jubilant Life Sciences Ltd, Key Competitors 30

Jubilant Life Sciences Ltd, Ratios based on current share price 31

Jubilant Life Sciences Ltd, Annual Ratios 32

Jubilant Life Sciences Ltd, Annual Ratios (Cont…1) 33

Jubilant Life Sciences Ltd, Annual Ratios (Cont…2) 34

Jubilant Life Sciences Ltd, Interim Ratios 36

Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 38

Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 39

Jubilant Life Sciences Ltd, Recent Deals Summary 40

Currency Codes 64

Capital Market Ratios 64

Equity Ratios 65

Profitability Ratios 65

Cost Ratios 66

Liquidity Ratios 66

Leverage Ratios 67

Efficiency Ratios 67

List of Figures

List of Figures

Jubilant Life Sciences Ltd, Performance Chart (2014 – 2018) 35

Jubilant Life Sciences Ltd, Ratio Charts 37

Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 38

Jubilant Life Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 39

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports